PREDICTORS OF USE OF LONG ACTING ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA

Basit Öğe Kaydı
dc.contributor.authorAlbayrak, Y.
dc.contributor.authorBeyazyuz, M.
dc.contributor.authorOzturk, N.
dc.contributor.authorKuloglu, M.
dc.date.accessioned2026-08-12T18:12:47Z
dc.date.issued2013
dc.departmentFırat Üniversitesi
dc.description21st European Congress of Psychiatry -- APR 06-09, 2013 -- Nice, FRANCE
dc.description.abstract[Abstract Not Available]
dc.identifier.issn0924-9338
dc.identifier.issn1778-3585
dc.identifier.urihttps://hdl.handle.net/11508/64046
dc.identifier.volume28
dc.identifier.wosWOS:000335460601513
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherCambridge Univ Press
dc.relation.ispartofEuropean Psychiatry
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titlePREDICTORS OF USE OF LONG ACTING ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu